Class information for:
Level 1: MORPHINE WITHDRAWAL//EQUIP CELLULAR MOL PHARMACOL//ACUTE DEPENDENCE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
10926 955 36.8 59%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
662 12640 NOCICEPTIN//ORPHANIN FQ//NOCICEPTIN ORPHANIN FQ

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 MORPHINE WITHDRAWAL Author keyword 35 36% 8% 80
2 EQUIP CELLULAR MOL PHARMACOL Address 30 100% 1% 12
3 ACUTE DEPENDENCE Author keyword 25 73% 2% 19
4 GRP CELLULAR MOL PHARMACOL Address 7 64% 1% 7
5 MORPHINE DEPENDENCE Author keyword 7 19% 3% 33
6 GRP PROGRAM NEUROSCI Address 6 71% 1% 5
7 NORADRENALINE TURNOVER Author keyword 6 41% 1% 11
8 CONDITIONED PLACE AVERSION Author keyword 5 21% 2% 21
9 MORPHINE CHALLENGE Author keyword 4 75% 0% 3
10 NTS A2 Author keyword 4 75% 0% 3

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 MORPHINE WITHDRAWAL 35 36% 8% 80 Search MORPHINE+WITHDRAWAL Search MORPHINE+WITHDRAWAL
2 ACUTE DEPENDENCE 25 73% 2% 19 Search ACUTE+DEPENDENCE Search ACUTE+DEPENDENCE
3 MORPHINE DEPENDENCE 7 19% 3% 33 Search MORPHINE+DEPENDENCE Search MORPHINE+DEPENDENCE
4 NORADRENALINE TURNOVER 6 41% 1% 11 Search NORADRENALINE+TURNOVER Search NORADRENALINE+TURNOVER
5 CONDITIONED PLACE AVERSION 5 21% 2% 21 Search CONDITIONED+PLACE+AVERSION Search CONDITIONED+PLACE+AVERSION
6 MORPHINE CHALLENGE 4 75% 0% 3 Search MORPHINE+CHALLENGE Search MORPHINE+CHALLENGE
7 NTS A2 4 75% 0% 3 Search NTS+A2 Search NTS+A2
8 OPIATE WITHDRAWAL 4 16% 2% 23 Search OPIATE+WITHDRAWAL Search OPIATE+WITHDRAWAL
9 NALOXONE PRECIPITATED WITHDRAWAL 4 33% 1% 9 Search NALOXONE+PRECIPITATED+WITHDRAWAL Search NALOXONE+PRECIPITATED+WITHDRAWAL
10 CATECHOLAMINERGIC ACTIVITY 3 100% 0% 3 Search CATECHOLAMINERGIC+ACTIVITY Search CATECHOLAMINERGIC+ACTIVITY

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 NALOXONE INDUCED WITHDRAWAL 46 82% 3% 27
2 OPIATE WITHDRAWAL 41 20% 19% 185
3 ACUTE PHYSICAL DEPENDENCE 29 63% 3% 30
4 BRIEF MORPHINE EXPOSURE 13 62% 1% 13
5 NALOXONE PRECIPITATED WITHDRAWAL 11 30% 3% 31
6 MORPHINE WITHDRAWAL 10 17% 6% 54
7 PRECIPITATED WITHDRAWAL 10 21% 4% 42
8 ACUTE OPIOID DEPENDENCE 9 64% 1% 9
9 CONDITIONED PLACE AVERSION 9 37% 2% 19
10 24 HOURS POSTMORPHINE 9 67% 1% 8

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Participation of noradrenergic pathways in the expression of opiate withdrawal: Biochemical and pharmacological evidence 1997 144 91 55%
Acute opioid dependence: characterizing the early adaptations underlying drug withdrawal 2005 24 129 48%
Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence 2008 87 192 11%
GABA and opioid mechanisms of the central amygdala underlie the withdrawal-potentiated startle from acute morphine 2009 13 70 37%
Reinforcement processes in opiate addiction: A homeostatic model 1996 67 67 33%
Ethological analysis of morphine withdrawal with different dependence programs in male mice 2002 14 37 54%
Involvement of the amygdala on place aversion induced by naloxone in single-dose morphine-treated rats 2008 4 47 51%
Low dose naltrexone administration in morphine dependent rats attenuates withdrawal-induced norepinephrine efflux in forebrain 2008 10 47 34%
Gabab receptors are involved in the control of acute opiate withdrawal in isolated tissue 1999 7 21 57%
GABA(A) receptor antagonists reduce acute opiate withdrawal in isolated tissue 1997 3 22 59%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 EQUIP CELLULAR MOL PHARMACOL 30 100% 1.3% 12
2 GRP CELLULAR MOL PHARMACOL 7 64% 0.7% 7
3 GRP PROGRAM NEUROSCI 6 71% 0.5% 5
4 NEUROPSYCHOBIOL DESAD TAT 2 19% 1.2% 11
5 GRP INFLAMMAT 2 67% 0.2% 2
6 CSV ARRIXACA HOSP 1 100% 0.2% 2
7 ADDICTEAM 1 50% 0.1% 1
8 AV DAVIS BEHAV NEUROBIOL 1 50% 0.1% 1
9 CHOLINERG NEUROPHARMACOL 1 50% 0.1% 1
10 EQUIP NEUROBIOL EXPT PHYSIOL 1 50% 0.1% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000185976 DEXTROMETHORPHAN//DIMEMORFAN//DEXTRORPHAN
2 0.0000176859 CONDITIONED PLACE PREFERENCE//PLACE CONDITIONING//INTRACRANIAL SELF ADMINISTRATION
3 0.0000166902 MU OPIOID RECEPTOR//OPIOID RECEPTOR//MOR 1
4 0.0000165345 DUODENAL DISTENSION//KATEDRA FIZJOL BIOCHEM FARMAKOL TOKSYKOL//EXPT CLIN PHYSIOPHARMACOL
5 0.0000131402 LOFEXIDINE//NALTREXONE//UNIT EDUC DRUGS ALCOHOL
6 0.0000089695 DRUG DISCRIMINATION//NOVEL RESPONSE PROCEDURE//TRAINING DOSE
7 0.0000068516 AFFILIATED OBSTET GYNECOL HOSP//MORPHINE 6 DEHYDROGENASE//ANTIOXIDASE
8 0.0000067206 REINSTATEMENT//SELF ADMINISTRATION//BEHAV NEUROSCI BRANCH
9 0.0000065638 CLING WRAP//DEPENDENCE PRODUCING DRUGS//LONG TERM EVALUATIONS
10 0.0000065038 PSYCHONEUROPHARMACOL//NORADRENALINE DOPAMINE INTERACTIONS//NOREPINEPHRINE DOPAMINE INTERACTIONS